Possible sarcopenia, sarcopenic obesity phenotypes and their association with diabetes: Evidence from LASI wave-1 (2017-18)

Quick takeaway

Cross-sectional evidence in Older adults in LASI Wave 1 national survey focused on national sarcopenia-phenotype and diabetes risk stratification analysis and tracked associations between diabetes and sarcopenia phenotype distributions. Useful for integrating sarcopenia screening into diabetes care where muscle loss and metabolic risk intersect.

Why this matters

Useful for integrating sarcopenia screening into diabetes care where muscle loss and metabolic risk intersect.

Key caution

The design can identify patterns and targets, but not prove that the observed association is causal.